Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

Lung-Targeted Lipid Nanoparticles Delivery of Wogonin for Pulmonary Fibrosis in Mice via Modulation of Cellular Proteostasis.

Wang L, Lin F, Gao F, Jia Z, Liu J, Liu X, Shang J, Ru X, Zhao Y, Zhao T, Yang L, Guo Y, Zhang M
International journal of nanomedicine
Aug 12, 2026
Sources
2 min read
0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

179 views
Share:

Abstract

<p>INTRODUCTION: Pulmonary fibrosis (PF) is a chronic and progressive lung disease characterized by excessive scarring of lung tissue, ultimately leading to impaired pulmonary function and poor survival outcomes. Currently, effective treatment options remain limited, with lung transplantation being the only definitive therapy. Wogonin, a bioactive flavonoid derived from the traditional Chinese medicinal herb Scutellaria baicalensis, has demonstrated potent anti-fibrotic effects in both in vitro and in vivo studies. However, its clinical application is hindered by poor tissue specificity, resulting in inadequate accumulation at fibrotic sites and low systemic bioavailability. METHODS: We developed a lung-targeted, wogonin-loaded lipid nanoparticle system (LNP-Wog). The stability and biocompatibility of LNP-Wog were systematically evaluated, and its anti-fibrotic efficacy was assessed in murine PF models. Proteomic analysis was conducted to identify key components of the LNP-associated "protein corona" responsible for lung targeting. Additionally, biotin-affinity pulldown assays combined with Gene Ontology (GO) enrichment analysis were performed to elucidate the underlying anti-fibrotic mechanisms of wogonin. RESULTS: LNP-Wog exhibited excellent stability, biocompatibility, and significant anti-fibrotic efficacy in murine PF models. Proteomic analysis revealed fibrinogen as a critical component of the LNP "protein corona", facilitating lung endothelial targeting through integrin-mediated interaction. Mechanistically, wogonin was found to localize to the endoplasmic reticulum, where it promotes proteostasis by inhibiting protein synthesis via enhanced phosphorylation of eIF2α, a key event in the integrated stress response. CONCLUSION: These findings underscore the therapeutic potential of lung-targeted LNP-Wog nanoparticles as a promising strategy for the treatment of pulmonary fibrosis.</p>

Related Topics

Substance
Health Topic
Action

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.